Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Feb 01, 2021 2:33pm
271 Views
Post# 32438580

RE:RE:Globe Newswire

RE:RE:Globe Newswire,,gv,,my guess is,,,, no partner,,,still talking,,,,and talking,,and more talking planned,,,,,basic timeline going to be given on BoM2,,,,,,,focus will try to be put on covid data/trial etc to get away from the partnership failure,,,, ,,nothing material,,,,,,I am not going to even log in to listen to all the Calgary excitiement incase I mt my bowels into my shorts,,,, this company is pitiable,,,,management is 8 years ahead of its shareholders not in epigenetic research.....thats a given,,the chart tells all,,,,it is the only truth here ,,,,,and charts never lie to shareholders,,,,again,,its something which each presentation should be forced to include!!!!!,,,no halt to trading on Thursday before the webcast,,then,,,it will be all lipstick on this proverbial pig,,,,this is my opinion,,,not anyone elses,,,,,,!
<< Previous
Bullboard Posts
Next >>